|Source:||The roots of Scutellaria regeliana Nakai|
|Biological Activity or Inhibitors:||1. Oroxylin A-7-O-glucuronide and wogonoside should also be served as the chemical markers together with baicalin for the quality control of herbs and proprietary traditional Chinese medicine (PTCM) products of radix Scutellariae.
2. Oroxylin A 7-O-glucuronide, Oroxin A, and Oroxin B can bind to the “stem” region of α-hemolysin (α-HL), when inhibiting the hemolytic activity of α-HL.
3. Oroxylin A 7-O-glucuronide and 4',5,7-trihydroxy-6-methoxyflavone at a concentration of 100 microM inhibit 34 and 43% of total prolyl oligopeptidase (POP) activity, respectively.
|Solvent:||Pyridine, Methanol, Ethanol, etc.|
|Storage:||Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: firstname.lastname@example.org
|After receiving:||The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.|
|1 mg||5 mg||10 mg||20 mg||25 mg|
|1 mM||2.1721 mL||10.8604 mL||21.7207 mL||43.4414 mL||54.3018 mL|
|5 mM||0.4344 mL||2.1721 mL||4.3441 mL||8.6883 mL||10.8604 mL|
|10 mM||0.2172 mL||1.086 mL||2.1721 mL||4.3441 mL||5.4302 mL|
|50 mM||0.0434 mL||0.2172 mL||0.4344 mL||0.8688 mL||1.086 mL|
|100 mM||0.0217 mL||0.1086 mL||0.2172 mL||0.4344 mL||0.543 mL|
Beijing Da Xue Xue Bao. 2009 Oct 18;41(5):578-84.
|Flavonoids from Scutellaria baicalensis and their bioactivities.[Pubmed: 19829679]|
|Nine compounds were isolated and identified as baicalein (1), wogonin (2), oroxylin A (3), 5, 7, 2', 6'-tetrahydroxyflavone (4), viscidulin III (5), baicalin (6), wogonoside (7), Oroxylin A 7-O-beta-D-glucuronide (8) and chrysin-6-C-alpha-L-arabinopyranosyl-8-C-beta-D-glucopyranoside (9). CONCLUSION: Baicalein had good anti-bacteria activity, and some compounds showed inhibiting activity against IL-1beta converting enzyme. The 13C NMR data of compounds 9 were assigned correctly by 2D nuclear magnetic resonance (NMR).|
J Pharm Biomed Anal. 2009 Oct 15;50(3):298-306.
|Contents of major bioactive flavones in proprietary traditional Chinese medicine products and reference herb of radix Scutellariae.[Pubmed: 19481403 ]|
|Contents of the six flavones were found to vary significantly among different products with glycosides, such as baicalin, wogonoside and oroxylin A-7-O-glucuronide(Oroxylin A 7-O-beta-D-glucuronide ), in much greater quantity than their corresponding aglycones. In addition to baicalin (18.54+/-0.71%, w/w), the commonly used marker compound for radix Scutellariae, wogonoside (3.54+/-0.18%, w/w) and oroxylin A-7-O-glucuronide (2.84+/-0.14%, w/w) also existed in abundant amount in the reference herb. Our findings suggested that wogonoside and oroxylin A-7-O-glucuronide should also be served as the chemical markers together with baicalin for the quality control of herbs and PTCM products of radix Scutellariae.|
Plos One, 2013, 8(11):e80197.
|Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin.[Reference: WebLink]|
|In this study, we found that three natural compounds, Oroxylin A 7-O-glucuronide (Oroxylin A 7-O-beta-D-glucuronide ,OLG), Oroxin A (ORA), and Oroxin B (ORB), when inhibiting the hemolytic activity of α-HL, could bind to the “stem” region of α-HL. This was completed using conventional Molecular Dynamics (MD) simulations. By interacting with the novel binding sites of α-HL, the ligands could form strong interactions with both sides of the binding cavity. The results of the principal component analysis (PCA) indicated that because of the inhibitors that bind to the “stem” region of α-HL, the conformational transition of α-HL from the monomer to the oligomer was restricted. This caused the inhibition of the hemolytic activity of α-HL. This novel inhibition mechanism has been confirmed by both the steered MD simulations and the experimental data obtained from a deoxycholate-induced oligomerization assay. This study can facilitate the design of new antibacterial drugs against S. aureus.|